Brief

"On 27 February 2025, the Ministry of Health and Welfare held the 2nd Advanced Regeneration Medical and Advanced Bio Pharmaceutical Review Committee. The committee reviewed clinical research plans submitted by regeneration medical institutions, including one on using patient-derived salivary gland stem cells (ATORM-S) to treat xerostomia in head and neck cancer patients, which was deemed unsuitable for approval, with the option for re-examination."

This content is restricted.

Highlights content goes here...

This content is restricted.

Ministry of Health and Welfare (MOHW)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies